Semax 'brain upgrade' claims: what 30 days of a peptide can and can't do

What did @courtcashwellness actually say?

The creator finished 30 days of semax and reported results they called "kind of insane." Specifically, they claimed "measurably improved" reaction time, "vastly better" memory, and improved mental resilience. The boldest claim: semax "works by increasing BDNF, which physically grows your brain." They also said it "changed the voice in my head" and altered their daily self-talk habits.

To be fair, they weren't selling a product directly, and they framed this as personal experience rather than a clinical recommendation. That matters. But 64,000 views means a lot of people are hearing "physically grows your brain" from a 30-day self-experiment, and that phrase deserves scrutiny.

Does the science back this up?

Partially, but the gap between what the research shows and what was claimed here is significant. Semax does have real pharmacological activity, and the BDNF connection is not invented. But "physically grows your brain" is a distortion of what the evidence actually says.

Semax is a synthetic heptapeptide derived from ACTH(4-7), developed in Russia in the 1980s. It has been studied primarily in animal models and in small Russian clinical trials focused on stroke recovery and cognitive impairment. A study by Dolotov et al. (2006, Journal of Neurochemistry) found that semax increased BDNF and its receptor TrkB mRNA expression in rat brain tissue. That's meaningful. BDNF supports neuronal survival and synaptic plasticity, processes loosely described as neuroplasticity.

But there's a large jump from "increases BDNF mRNA in rat brains" to "physically grows your brain" in a healthy human over 30 days. No published human trial has demonstrated measurable brain volume changes from semax use. The neuroplasticity research on BDNF in humans is correlational at best in most contexts, and semax-specific human RCTs are essentially absent from Western peer-reviewed literature.

What did they get wrong (or right)?

The BDNF claim is directionally right but framed irresponsibly. Semax does appear to upregulate BDNF signaling in animal research. Credit for that. But "physically grows your brain" is not what that means, and saying so to a mass audience is misleading.

The self-reported outcomes, sharper focus, better memory, improved self-talk, are unverifiable from a single user's 30-day account. This isn't a knock on the creator specifically. Self-reported cognitive improvements are notoriously confounded by expectation effects. A 2019 meta-analysis by Mancuso et al. (Neuroscience and Biobehavioral Reviews) found placebo response rates in cognitive enhancement trials frequently exceed 30 percent, particularly for subjective outcomes like "mental clarity."

The claim that reaction time was "measurably improved" is interesting. If they used an actual tool like a validated reaction-time app before and after, that's more than most biohackers do. But without a control condition, it's still weak evidence. Sleep quality, caffeine intake, and practice effects all confound reaction time over 30 days.

What they got right: semax is a real compound with real preclinical data, not a supplement industry invention. The BDNF mechanism is grounded in published research. The framing as a personal experience rather than a treatment recommendation also keeps this from being the most irresponsible peptide content on TikTok, though the "brain-building peptide" language in the caption pushes toward that territory.

What should you actually know?

Semax is not approved by the FDA. In the United States, it exists in a regulatory gray zone, available through compounding pharmacies under specific circumstances, but not as an over-the-counter supplement or a proven cognitive enhancer. Anyone considering it should know this upfront.

The human evidence base is thin. Most published clinical work on semax comes from Russian literature, often with small sample sizes and limited independent replication. A review by Lebedeva et al. (2018, Zhurnal Nevrologii i Psikhiatrii) examined semax in ischemic stroke patients and found some promising signals, but stroke recovery is a very different context than healthy-person cognitive optimization.

Intranasal peptides like semax also raise real questions about bioavailability and dosing consistency that single-user reports cannot answer. The safety profile in healthy individuals over extended use is not well characterized in peer-reviewed literature.

If you are interested in supporting BDNF through evidence-backed means, aerobic exercise has the strongest human RCT support for increasing BDNF and improving cognitive outcomes (Szabo et al., 2023, Neuroscience and Biobehavioral Reviews). That is not a dismissal of peptide research, it is context that a 64,000-view video should probably include.